FDA approves first presbyopia eye drop

US regulators have approved the country’s first presbyopia eye drop that adopts pupil constriction to improve near and intermediate vision while maintaining some pupillary response to different lighting conditions.
Read More
Azura Ophthalmics meibomian gland dysfunction

Ikervis ciclosporin eye drop now PBS-listed

Pharmaceutical firm Seqirus has announced that its new therapy Ikervis is now available via the Pharmaceutical Benefits Scheme (PBS), making it Australia’s first listed disease modifying ciclosporin eye drop for severe keratitis in adults with dry eye disease (DED). Read More

Complaints over compounded atropine eye drops in NSW

The Pharmacy Council of New South Wales has reported a rise in complaints over compounded atropine eye drops, with one patient lodging their grievance with Ahpra after becoming aware the formulation was not prepared under sterile conditions.
Read More